How Big Pharma Turned Cancer into a Goldmine
The cancer industry is raking in a staggering $222 billion annually, with its relentless pursuit of profit often taking precedence over the well-being of patients. This multibillion-dollar behemoth is driven by insatiable greed, as numerous stakeholders prioritize their bottom line over the development and dissemination of effective treatments, thereby perpetuating a culture of exploitation that […]